These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18654660)

  • 1. Protein complex, gene, and regulatory modules in cancer heterogeneity.
    Papanikolaou NA; Papavassiliou AG
    Mol Med; 2008; 14(9-10):543-5. PubMed ID: 18654660
    [No Abstract]   [Full Text] [Related]  

  • 2. Signaling via PINCH: Functions, binding partners and implications in human diseases.
    Xu H; Cao H; Xiao G
    Gene; 2016 Dec; 594(1):10-15. PubMed ID: 27590440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying the dynamics of SLP-76, Nck, and Vav1 multimolecular complex formation in live human cells with triple-color FRET.
    Pauker MH; Hassan N; Noy E; Reicher B; Barda-Saad M
    Sci Signal; 2012 Apr; 5(221):rs3. PubMed ID: 22534133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Beclin 1-Mediated Autophagy by Oncogenic Tyrosine Kinases.
    Vega-Rubín-de-Celis S; Kinch L; Peña-Llopis S
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.
    McDonald ER; de Weck A; Schlabach MR; Billy E; Mavrakis KJ; Hoffman GR; Belur D; Castelletti D; Frias E; Gampa K; Golji J; Kao I; Li L; Megel P; Perkins TA; Ramadan N; Ruddy DA; Silver SJ; Sovath S; Stump M; Weber O; Widmer R; Yu J; Yu K; Yue Y; Abramowski D; Ackley E; Barrett R; Berger J; Bernard JL; Billig R; Brachmann SM; Buxton F; Caothien R; Caushi JX; Chung FS; Cortés-Cros M; deBeaumont RS; Delaunay C; Desplat A; Duong W; Dwoske DA; Eldridge RS; Farsidjani A; Feng F; Feng J; Flemming D; Forrester W; Galli GG; Gao Z; Gauter F; Gibaja V; Haas K; Hattenberger M; Hood T; Hurov KE; Jagani Z; Jenal M; Johnson JA; Jones MD; Kapoor A; Korn J; Liu J; Liu Q; Liu S; Liu Y; Loo AT; Macchi KJ; Martin T; McAllister G; Meyer A; Mollé S; Pagliarini RA; Phadke T; Repko B; Schouwey T; Shanahan F; Shen Q; Stamm C; Stephan C; Stucke VM; Tiedt R; Varadarajan M; Venkatesan K; Vitari AC; Wallroth M; Weiler J; Zhang J; Mickanin C; Myer VE; Porter JA; Lai A; Bitter H; Lees E; Keen N; Kauffmann A; Stegmeier F; Hofmann F; Schmelzle T; Sellers WR
    Cell; 2017 Jul; 170(3):577-592.e10. PubMed ID: 28753431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Complexity of DEK Signaling in Cancer Progression.
    Teng Y; Lang L; Jauregui CE
    Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR in aging, metabolism, and cancer.
    Cornu M; Albert V; Hall MN
    Curr Opin Genet Dev; 2013 Feb; 23(1):53-62. PubMed ID: 23317514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4E-BP1, a multifactor regulated multifunctional protein.
    Qin X; Jiang B; Zhang Y
    Cell Cycle; 2016; 15(6):781-6. PubMed ID: 26901143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncogenic role of Jagged1/Notch signaling in cancer.
    Xiu MX; Liu YM; Kuang BH
    Biomed Pharmacother; 2020 Sep; 129():110416. PubMed ID: 32593969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome complexity and the forces that drive proteome imbalance.
    Harper JW; Bennett EJ
    Nature; 2016 Sep; 537(7620):328-38. PubMed ID: 27629639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3: a multifaceted oncogene.
    Levy DE; Inghirami G
    Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10151-10152. PubMed ID: 16801534
    [No Abstract]   [Full Text] [Related]  

  • 12. The oncogenic potential of NANOG: An important cancer induction mediator.
    Najafzadeh B; Asadzadeh Z; Motafakker Azad R; Mokhtarzadeh A; Baghbanzadeh A; Alemohammad H; Abdoli Shadbad M; Vasefifar P; Najafi S; Baradaran B
    J Cell Physiol; 2021 Apr; 236(4):2443-2458. PubMed ID: 32960465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenes as therapeutic targets.
    Felsher DW
    Semin Cancer Biol; 2004 Feb; 14(1):1. PubMed ID: 14757530
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of the gene regulatory network identifies MYC as a transcriptional regulator of SWI/SNF complex.
    Srikanth S; Ramachandran S; Mohan S S
    Sci Rep; 2020 Jan; 10(1):158. PubMed ID: 31932624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p27: tumor suppressor and oncogene ...?
    Kossatz U; Malek NP
    Cell Res; 2007 Oct; 17(10):832-3. PubMed ID: 17934492
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging role of ZBTB7A as an oncogenic driver and transcriptional repressor.
    Gupta S; Singh AK; Prajapati KS; Kushwaha PP; Shuaib M; Kumar S
    Cancer Lett; 2020 Jul; 483():22-34. PubMed ID: 32348807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ENTPD5 splice variants: novel players in cancer?
    Arruga F
    Purinergic Signal; 2021 Sep; 17(3):317-318. PubMed ID: 34272651
    [No Abstract]   [Full Text] [Related]  

  • 18. Oncogenic kinase signalling.
    Blume-Jensen P; Hunter T
    Nature; 2001 May; 411(6835):355-65. PubMed ID: 11357143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why are the truncated cyclin Es more effective CDK2 activators than the full-length isoforms?
    Rath SL; Senapati S
    Biochemistry; 2014 Jul; 53(28):4612-24. PubMed ID: 24947816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Opposing Roles of PIK3R1/p85α and PIK3R2/p85β in Cancer.
    Vallejo-Díaz J; Chagoyen M; Olazabal-Morán M; González-García A; Carrera AC
    Trends Cancer; 2019 Apr; 5(4):233-244. PubMed ID: 30961830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.